A mutant library of 249 mutants with mutations that span the entire Epstein–Barr virus (EBV) genome was generated by transposition with EZ : : TN <KAN-2> and insertion with an apramycin resistance gene by a PCR-targeting method. This study also demonstrates the feasibility of generating deletions and site-specific mutations in the BRLF1 promoter on the EBV genome to determine the regions in the promoter that are crucial to transcription. Analysing BZLF1 and BRLF1 mutants by microarray analysis revealed that these two genes regulate the transcription of EBV lytic genes differently. A BZLF1 mutation affects global expression of EBV lytic genes; almost no lytic gene is expressed by the mutant after lytic induction. However, although a BRLF1 mutant still transcribes most lytic genes, the expression of these lytic genes is inefficient. Furthermore, this study shows that the proximal Zta-response element in the BRLF1 promoter is crucial to BRLF1 transcription from the EBV genome, despite the fact that another work demonstrated that this site was unimportant in transient transfection analysis. Furthermore, mutants with a mutation in BDLF1 and BORF1 cannot assemble viral capsids. Results of this study demonstrate the usefulness of a comprehensive mutant library in genetic analyses of EBV.
AhsanN.,
KandaT.,
NagashimaK.,
TakadaK.2005; Epstein-Barr virus transforming protein LMP1 plays a critical role in virus production. J Virol 79:4415–4424[CrossRef]
AltmannM.,
PichD.,
RuissR.,
WangJ.,
SugdenB.,
HammerschmidtW.2006; Transcriptional activation by EBV nuclear antigen 1 is essential for the expression of EBV's transforming genes. Proc Natl Acad Sci U S A 103:14188–14193[CrossRef]
AsaiR.,
KatoA.,
KatoK.,
Kanamori-KoyamaM.,
SugimotoK.,
SairenjiT.,
NishiyamaY.,
KawaguchiY.2006; Epstein-Barr virus protein kinase BGLF4 is a virion tegument protein that dissociates from virions in a phosphorylation-dependent process and phosphorylates the viral immediate-early protein BZLF1. J Virol 80:5125–5134[CrossRef]
BhendeP. M.,
SeamanW. T.,
DelecluseH. J.,
KenneyS. C.2005; BZLF1 activation of the methylated form of the BRLF1 immediate-early promoter is regulated by BZLF1 residue 186. J Virol 79:7338–7348[CrossRef]
ChangL. K.,
LiuS. T.2000; Activation of the BRLF1 promoter and lytic cycle of Epstein–Barr virus by histone acetylation. Nucleic Acids Res 28:3918–3925[CrossRef]
ChangL. K.,
ChungJ. Y.,
HongY. R.,
IchimuraT.,
NakaoM.,
LiuS. T.2005; Activation of Sp1-mediated transcription by Rta of Epstein–Barr virus via an interaction with MCAF1. Nucleic Acids Res 33:6528–6539[CrossRef]
ChauC. M.,
ZhangX. Y.,
McMahonS. B.,
LiebermanP. M.2006; Regulation of Epstein-Barr virus latency type by the chromatin boundary factor CTCF. J Virol 80:5723–5732[CrossRef]
ChenA.,
DivisconteM.,
JiangX.,
QuinkC.,
WangF.2005; Epstein-Barr virus with the latent infection nuclear antigen 3B completely deleted is still competent for B-cell growth transformation in vitro. J Virol 79:4506–4509[CrossRef]
CollinsC. M.,
MedveczkyM. M.,
LundT.,
MedveczkyP. G.2002; The terminal repeats and latency-associated nuclear antigen of herpesvirus saimiri are essential for episomal persistence of the viral genome. J Gen Virol 83:2269–2278
DatsenkoK. A.,
WannerB. L.2000; One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 97:6640–6645[CrossRef]
DecaussinG.,
LeclercV.,
OokaT.1995; The lytic cycle of Epstein-Barr virus in the nonproducer Raji line can be rescued by the expression of a 135-kilodalton protein encoded by the BALF2 open reading frame. J Virol 69:7309–7314
DelecluseH. J.,
HilsendegenT.,
PichD.,
ZeidlerR.,
HammerschmidtW.1998; Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells. Proc Natl Acad Sci U S A 95:8245–8250[CrossRef]
DelecluseH. J.,
PichD.,
HilsendegenT.,
BaumC.,
HammerschmidtW.1999; A first-generation packaging cell line for Epstein-Barr virus-derived vectors. Proc Natl Acad Sci U S A 96:5188–5193[CrossRef]
DirmeierU.,
NeuhierlB.,
KilgerE.,
ReisbachG.,
SandbergM. L.,
HammerschmidtW.2003; Latent membrane protein 1 is critical for efficient growth transformation of human B cells by Epstein-Barr virus. Cancer Res 63:2982–2989
FeederleR.,
DelecluseH. J.2004; Low level of lytic replication in a recombinant Epstein-Barr virus carrying an origin of replication devoid of BZLF1-binding sites. J Virol 78:12082–12084[CrossRef]
FeederleR.,
KostM.,
BaumannM.,
JanzA.,
DrouetE.,
HammerschmidtW.,
DelecluseH. J.2000; The Epstein–Barr virus lytic program is controlled by the co-operative functions of two transactivators. EMBO J 19:3080–3089[CrossRef]
FeederleR.,
NeuhierlB.,
BaldwinG.,
BannertH.,
HubB.,
MautnerJ.,
BehrendsU.,
DelecluseH. J.2006; Epstein-Barr virus BNRF1 protein allows efficient transfer from the endosomal compartment to the nucleus of primary B lymphocytes. J Virol 80:9435–9443[CrossRef]
GrabusicK.,
MaierS.,
HartmannA.,
MantikA.,
HammerschmidtW.,
KempkesB.2006; The CR4 region of EBNA2 confers viability of Epstein–Barr virus-transformed B cells by CBF1-independent signalling. J Gen Virol 87:3169–3176[CrossRef]
GustB.,
ChallisG. L.,
FowlerK.,
KieserT.,
ChaterK. F.2003; PCR-targeted Streptomyces gene replacement identifies a protein domain needed for biosynthesis of the sesquiterpene soil odor geosmin. Proc Natl Acad Sci U S A 100:1541–1546[CrossRef]
HoS. N.,
HuntH. D.,
HortonR. M.,
PullenJ. K.,
PeaseL. R.1989; Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77:51–59[CrossRef]
HongG. K.,
DelecluseH. J.,
GruffatH.,
MorrisonT. E.,
FengW. H.,
SergeantA.,
KenneyS. C.2004; The BRRF1 early gene of Epstein-Barr virus encodes a transcription factor that enhances induction of lytic infection by BRLF1. J Virol 78:4983–4992[CrossRef]
HummeS.,
ReisbachG.,
FeederleR.,
DelecluseH. J.,
BoussetK.,
HammerschmidtW.,
SchepersA.2003; The EBV nuclear antigen 1 (EBNA1) enhances B cell immortalization several thousandfold. Proc Natl Acad Sci U S A 100:10989–10994[CrossRef]
HutchingsI. A.,
TierneyR. J.,
KellyG. L.,
StylianouJ.,
RickinsonA. B.,
BellA. I.2006; Methylation status of the Epstein-Barr virus (EBV) Bam HI W latent cycle promoter and promoter activity: analysis with novel EBV-positive Burkitt and lymphoblastoid cell lines. J Virol 80:10700–10711[CrossRef]
KandaT.,
YajimaM.,
AhsanN.,
TanakaM.,
TakadaK.2004; Production of high-titer Epstein-Barr virus recombinants derived from Akata cells by using a bacterial artificial chromosome system. J Virol 78:7004–7015[CrossRef]
KellyG. L.,
MilnerA. E.,
TierneyR. J.,
Croom-CarterD. S.,
AltmannM.,
HammerschmidtW.,
BellA. I.,
RickinsonA. B.2005; Epstein-Barr virus nuclear antigen 2 (EBNA2) gene deletion is consistently linked with EBNA3A, -3B, and -3C expression in Burkitt's lymphoma cells and with increased resistance to apoptosis. J Virol 79:10709–10717[CrossRef]
LuC. C.,
JengY. Y.,
TsaiC. H.,
LiuM. Y.,
YehS. W.,
HsuT. Y.,
ChenM. R.2006; Genome-wide transcription program and expression of the Rta responsive gene of Epstein-Barr virus. Virology 345:358–372[CrossRef]
RyanJ. L.,
FanH.,
GlaserS. L.,
SchichmanS. A.,
Raab-TraubN.,
GulleyM. L.2004; Epstein-Barr virus quantitation by real-time PCR targeting multiple gene segments: a novel approach to screen for the virus in paraffin-embedded tissue and plasma. J Mol Diagn 6:378–385[CrossRef]
Shannon-LoweC. D.,
NeuhierlB.,
BaldwinG.,
RickinsonA. B.,
DelecluseH. J.2006; Resting B cells as a transfer vehicle for Epstein-Barr virus infection of epithelial cells. Proc Natl Acad Sci U S A 103:7065–7070[CrossRef]
SkareJ.,
FarleyJ.,
StromingerJ. L.,
FresenK. O.,
ChoM. S.,
zur HausenH.1985; Transformation by Epstein-Barr virus requires DNA sequences in the region of Bam HI fragments Y and H. J Virol 55:286–297
SongM. J.,
HwangS.,
WongW. H.,
WuT. T.,
LeeS.,
LiaoH. I.,
SunR.2005; Identification of viral genes essential for replication of murine gamma-herpesvirus 68 using signature-tagged mutagenesis. Proc Natl Acad Sci U S A 102:3805–3810[CrossRef]
WangJ. T.,
YangP. W.,
LeeC. P.,
HanC. H.,
TsaiC. H.,
ChenM. R.2005; Detection of Epstein–Barr virus BGLF4 protein kinase in virus replication compartments and virus particles. J Gen Virol 86:3215–3225[CrossRef]
ZalaniS.,
Holley-GuthrieE. A.,
GutschD. E.,
KenneyS. C.1992; The Epstein-Barr virus immediate-early promoter BRLF1 can be activated by the cellular Sp1 transcription factor. J Virol 66:7282–7292